P2Y₁₂ is a chemoreceptor for adenosine diphosphate that belongs to the Gᵢ class of a group of G protein-coupled purinergic receptors. From Wikipedia
A meta-analysis of five trials in more than 16,000 patients showed a 23% drop in major cardiovascular events over four years with P2Y12 monotherapy replacing aspirin
